Evidence map›Paper›PMID 39131286›Full record

ArticlebioRxiv : the preprint server for biology2024

A bacterial TIR-based immune system senses viral capsids to initiate defense.

Cameron G Roberts, Chloe B Fishman, Dalton V Banh, Luciano A Marraffini

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Cameron G RobertsLaboratory of Bacteriology, The Rockefeller University, 1230 York Ave, New York, NY 10065, USA.ORCID 0000-0002-0115-7013
Chloe B FishmanLaboratory of Bacteriology, The Rockefeller University, 1230 York Ave, New York, NY 10065, USA.ORCID 0000-0002-4698-4469
Dalton V BanhLaboratory of Bacteriology, The Rockefeller University, 1230 York Ave, New York, NY 10065, USA.ORCID 0000-0001-8167-9358
Luciano A MarraffiniLaboratory of Bacteriology, The Rockefeller University, 1230 York Ave, New York, NY 10065, USA.ORCID 0000-0002-9163-0969

Funding

Weill Cornell/Rockefeller/Sloan Kettering MST ProgramT32GM152349 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KATHARINE C HSU · 2024 to 2026
$6.6M
Elucidating how CRISPR-Cas Modulates the Spread of S. aureus Pathogenicity IslandsF30AI157535 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI BANH, DALTON VAN · 2021 to 2024
$203k
NIAID NIH HHS F30 AI157535NIGMS NIH HHS T32 GM152349
6 · The paper itself

Abstract

Toll/interleukin-1 receptor (TIR) domains are present in immune systems that protect prokaryotes from viral (phage) attack. In response to infection, TIRs can produce a cyclic adenosine diphosphate-ribose (ADPR) signaling molecule, which activates an effector that depletes the host of the essential metabolite NAD+ to limit phage propagation. How bacterial TIRs recognize phage infection is not known. Here we describe the sensing mechanism for the staphylococcal Thoeris defense system, which consists of two TIR domain sensors, ThsB1 and ThsB2, and the effector ThsA. We show that the major capsid protein of phage Φ80α forms a complex with ThsB1 and ThsB2, which is sufficient for the synthesis of 1"-3' glycocyclic ADPR (gcADPR) and subsequent activation of NAD+ cleavage by ThsA. Consistent with this, phages that escape Thoeris immunity harbor mutations in the capsid that prevent complex formation. We show that capsid proteins from staphylococcal Siphoviridae belonging to the capsid serogroup B, but not A, are recognized by ThsB1/B2, a result that suggests that capsid recognition by Sau-Thoeris and other anti-phage defense systems may be an important evolutionary force behind the structural diversity of prokaryotic viruses. More broadly, since mammalian toll-like receptors harboring TIR domains can also recognize viral structural components to produce an inflammatory response against infection, our findings reveal a conserved mechanism for the activation of innate antiviral defense pathways.

Identifiers

PMID39131286
PMCPMC11312562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.